DoriTri® contains three active ingredients in a medically meaningful combination. Provides fast and lasting effective help for sore throat.
The effect of DoriTri® is based on its unique active ingredient formula: A local pain-relieving agent, a local antibiotic and a local antiseptic agent complement and support each other in their effects. Additionally, DoriTri® does NOT cause unpleasant numbness in the mouth.
In addition to the local pain-relieving agent, DoriTri® contains two other active ingredients that complement each other in their effect and also target the pathogens during treatment: the antibiotic in particular plays a central role here, since it not only has excellent antibacterial properties, but also exerts an antiviral effect in combination with the other active ingredients, thus targeting multiple virus strains known as “cold viruses”. Last, but not least, the antibiotic is known for its local immune-stimulating properties. This supports the body’s own defences in the fight against the pathogens and slows down the infection. A local antiseptic with disinfectant properties supplements the active formula of DoriTri® in a meaningful way and completes the unique combination of active ingredients in DoriTri®.
DoriTri® – evidence-based medicine. In a placebo-controlled, double-blind study1, DoriTri® once again confirmed its effectiveness and tolerability in the treatment of sore throat.
DoriTri® also specifically targets bacteria and viruses2.
1 Placebokontrollierte Studie zum Nachweis der Wirksamkeit und Sicherheit von Dorithricin® mit 312 Patienten, Palm et al., Int J Clin Pract. 2018; e13272.
2 Schmidbauer M., 2015: Dorithricin® wirkt antiviral (in vitro). Pharm. Ztg., 160. Jahrgang, 38. Ausg.: S. 48–52.
LOCAL ANTIBIOTIC: Tyrothricin 0.5 mg AB peptide, denatured and broken down in the stomach, no effect on intestinal flora, no systemic side effects
LOCAL ANTISEPTIC: Benzalkonium chloride 1.0 mg
LOCAL ANESTHETIC: Benzocaine pain reliever 1,5 mg, does not cause unnecessary anesthesia
OTC STATUS